CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
DEFA5 | Defensin, alpha 5, Paneth cell-specific | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
DEFA6 | Defensin, alpha 6, Paneth cell-specific | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
DEPDC7 | DEP domain containing 7 | | | | | | Group enriched |
DGAT1 | Diacylglycerol O-acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes
| | | | | Group enriched |
DHRS11 | Dehydrogenase/reductase (SDR family) member 11 | | | | | | Group enriched |
DMBT1 | Deleted in malignant brain tumors 1 | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | CD markers Enzymes Plasma proteins
| | | | | Group enriched |
ENPP7 | Ectonucleotide pyrophosphatase/phosphodiesterase 7 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
EPS8L3 | EPS8-like 3 | | | | | | Group enriched |
ERN2 | Endoplasmic reticulum to nucleus signaling 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FABP1 | Fatty acid binding protein 1, liver | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FCGBP | Fc fragment of IgG binding protein | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FOXA3 | Forkhead box A3 | Transcription factors
| | | | | Group enriched |
GDPD2 | Glycerophosphodiester phosphodiesterase domain containing 2 | Cytoskeleton related proteins Enzymes Predicted membrane proteins
| | | | | Group enriched |
GIP | Gastric inhibitory polypeptide | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GLTPD2 | Glycolipid transfer protein domain containing 2 | Predicted secreted proteins
| | | | | Group enriched |
GOLT1A | Golgi transport 1A | Predicted membrane proteins
| | | | | Group enriched |
GPA33 | Glycoprotein A33 (transmembrane) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
GPR112 | G protein-coupled receptor 112 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
GUCA2B | Guanylate cyclase activator 2B (uroguanylin) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
GUCY2C | Guanylate cyclase 2C (heat stable enterotoxin receptor) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
HHLA2 | HERV-H LTR-associating 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
IGSF23 | Immunoglobulin superfamily, member 23 | Predicted membrane proteins
| | | | | Group enriched |
IHH | Indian hedgehog | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ISX | Intestine-specific homeobox | Transcription factors
| | | | | Group enriched |
ITLN1 | Intelectin 1 (galactofuranose binding) | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
ITLN2 | Intelectin 2 | Predicted secreted proteins
| | | | | Group enriched |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes
| | | | | Group enriched |
KCNJ3 | Potassium inwardly-rectifying channel, subfamily J, member 3 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNK16 | Potassium channel, subfamily K, member 16 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KDM8 | Lysine (K)-specific demethylase 8 | Enzymes
| | | | | Group enriched |
KHK | Ketohexokinase (fructokinase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
KRT20 | Keratin 20 | Plasma proteins
| | | | | Group enriched |
LCN15 | Lipocalin 15 | Predicted secreted proteins
| | | | | Group enriched |
LCT | Lactase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
LINC00955 | Long intergenic non-protein coding RNA 955 | Predicted membrane proteins
| | | | | Group enriched |
MAB21L2 | Mab-21-like 2 (C. elegans) | | | | | | Group enriched |
MALRD1 | MAM and LDL receptor class A domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MEP1B | Meprin A, beta | Enzymes Predicted membrane proteins
| | | | | Group enriched |
MGAM | Maltase-glucoamylase (alpha-glucosidase) | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MOGAT2 | Monoacylglycerol O-acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
MS4A10 | Membrane-spanning 4-domains, subfamily A, member 10 | Predicted membrane proteins Transporters
| | | | | Group enriched |
MS4A8 | Membrane-spanning 4-domains, subfamily A, member 8 | Predicted membrane proteins
| | | | | Group enriched |